For Cancer Patients
Intravenous high-dose vitamin C (IVC) is being explored as a complementary therapy in oncology. Some studies suggest that IVC may enhance the effectiveness of chemotherapy and radiation therapy, potentially improving patient outcomes. For instance, a phase II clinical trial indicated that adding high-dose IVC to chemotherapy doubled the overall survival time in patients with advanced pancreatic cancer from 8 to 16 months .
Additionally, IVC may help reduce chemotherapy-related side effects, such as fatigue and nausea, thereby improving quality of life . However, it’s important to note that while these findings are promising, more extensive randomized controlled trials are needed to establish definitive benefits.
request an appointment
For Long COVID Syndrome
High-dose IVC is also being investigated for its potential to alleviate symptoms associated with long COVID, such as fatigue, cognitive difficulties, and inflammation. Its antioxidant and anti-inflammatory properties may help mitigate oxidative stress and support immune function .
Some reports suggest that IVC therapy can reduce fatigue and improve concentration in long COVID patients . Nevertheless, further research is required to confirm these effects and determine optimal dosing protocols.